Recent investigations are opening up exciting new frontiers in managing this neurological disorder. Focus is increasingly on DMTs that not only slow disease advancement, but also regenerate damaged myelin. Cutting-edge approaches encompass potential therapies modulating specific immune response aspects and assessing the usefulness of regenerative m